Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as it marks Bio-Thera’s third EC approvedproduct” said Shengfeng Li, CEO at Bio-Thera. “Bio-Thera is committed toexpanding access fo...
View DetailsGuangzhou, China --(BUSINESSWIRE)-- Bio-TheraSolutions, Ltd. (SH: 688177),a commercial-stage biopharmaceutical company, today announced that dosing hasbegun in a Phase I clinical study to compare the pharmacokinetics and safety ofBAT2606, a proposed ...
Guangzhou,China --(BUSINESSWIRE)-- Bio-Thera Solutions, Ltd. (SH: 688177), acommercial-stage biopharmaceutical company, announced today the details of its poster presentation at the VaccinesSummit 2022, being held fromOctober 11-13inWashingtonD.C. Bi...
FRα is a folicacid-binding protein located on cell membranes that is overexpressed in avariety of solid tumors such as ovarian, lung, breast cancer, etc., but has alimited distribution and a lower level of expression in normal human tissues.Differenc...
